Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-679P (RNA, U6 small nuclear 679, pseudogene) is a processed pseudogene related to U6 small nuclear RNA (snRNA) in the human genome. Canonical U6 snRNA is an essential non-coding RNA component of the spliceosome: it is required for the removal of introns from pre-mRNA during splicing and is highly conserved and structurally complex[1][3]. However, as a pseudogene, RNU6-679P is a non-functional copy and generally does not encode an active RNA species or protein. Pseudogenes can sometimes be transcribed and serve as regulatory RNAs, influencing cellular gene expression by sponging microRNAs, generating siRNAs, or modulating RNA-binding protein availability[2]. There are no reports of RNU6-679P acting as a receptor, enzyme, transporter, or direct therapeutic target, and it is not associated with drug interactions or used as a biomarker in current clinical practice. Like other pseudogenes, its primary significance is genomic, and any functional role would be mediated through RNA-based regulatory networks if such transcription occurs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on U6 small nuclear RNA 679, pseudogene (RNU6-679P).